Several clinical studies have reported that elevated lactate concentrations in serum or bile, as well as high LDHA expression in tumor tissue, are associated with metabolic reprogramming, higher pathological grade and stage, and poorer prognosis, suggesting that LDHA-related lactate metabolism may serve as a potential prognostic marker in GBC. This evidence concerns the gene LDHA and neoplasm.